Apoptotic Pathways and Therapy Resistance in Human Malignancies
- 9 August 2005
- book chapter
- Published by Elsevier
- Vol. 94, 143-196
- https://doi.org/10.1016/s0065-230x(05)94004-9
Abstract
No abstract availableKeywords
This publication has 244 references indexed in Scilit:
- Small molecules that reactivate mutant p53European Journal Of Cancer, 2003
- Involvement of the p38 mitogen-activated protein kinase cascade in hepatocellular carcinomaCancer, 2003
- Live or let die: the cell's response to p53Nature Reviews Cancer, 2002
- Targeting death and decoy receptors of the tumour-necrosis factor superfamilyNature Reviews Cancer, 2002
- Human caspase 12 has acquired deleterious mutationsBiochemical and Biophysical Research Communications, 2002
- p63 and p73 are required for p53-dependent apoptosis in response to DNA damageNature, 2002
- Bcl-XL is a chemoresistance factor in human melanoma cells that can be inhibited by antisense therapyInternational Journal of Cancer, 2002
- Restoration of the tumor suppressor function to mutant p53 by a low-molecular-weight compoundNature Medicine, 2002
- Downregulation of Proapoptotic Proteins Bax and Bcl-XS in p53 Overexpressing Hepatocellular CarcinomasBiochemical and Biophysical Research Communications, 2000
- The Hallmarks of CancerCell, 2000